ESMO 2014 – Gastrointestinal and Head & Neck Cancer

Afatinib Improves Outcomes in Patients with Head and Neck Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer

Interim Analysis of BATON-CRC: Tivozanib plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer

Cetuximab, Fluorouracil, and Cisplatin, with/without Docetaxel, in Recurrent or Metastatic Head and Neck Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer

Pembrolizumab in HPV-Positive Head and Neck Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer

Association of HPV and p16 Status with Cetuximab plus Radiotherapy in Locally Advanced Head and Neck Cancer

ESMO 2014 – Gastrointestinal and Head & Neck Cancer